HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,612,726 | +65.9% | 173,108 | +56.7% | 0.04% | +75.0% |
| Q2 2023 | $3,985,014 | -21.7% | 110,480 | -17.1% | 0.02% | -28.6% |
| Q1 2023 | $5,087,214 | -15.3% | 133,208 | +26.2% | 0.03% | -20.0% |
| Q4 2022 | $6,005,169 | +263.7% | 105,539 | +181.3% | 0.04% | +250.0% |
| Q2 2022 | $1,651,000 | +624.1% | 37,513 | +603.5% | 0.01% | +900.0% |
| Q4 2020 | $228,000 | +53.0% | 5,332 | -54.1% | 0.00% | 0.0% |
| Q2 2017 | $149,000 | -47.2% | 11,625 | -42.2% | 0.00% | -50.0% |
| Q1 2014 | $282,000 | – | 20,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |